Ernest Smith

1.1k total citations
29 papers, 660 citations indexed

About

Ernest Smith is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Ernest Smith has authored 29 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Ernest Smith's work include Axon Guidance and Neuronal Signaling (15 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (4 papers). Ernest Smith is often cited by papers focused on Axon Guidance and Neuronal Signaling (15 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (4 papers). Ernest Smith collaborates with scholars based in United States, Germany and Canada. Ernest Smith's co-authors include Maurice Zauderer, Elizabeth E. Evans, Alan S. Jonason, Christine Reilly, Mark Paris, Laurie A. Winter, Terrence L. Fisher, Crystal Mallow, Sebold Torno and Holm Bußler and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ernest Smith

28 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ernest Smith United States 13 280 251 184 160 57 29 660
Ashley N. Davis United States 8 354 1.3× 223 0.9× 146 0.8× 121 0.8× 20 0.4× 10 565
Sabrina A. Volpi United States 8 389 1.4× 167 0.7× 236 1.3× 42 0.3× 51 0.9× 9 667
Cheryl D’Souza Canada 13 251 0.9× 106 0.4× 219 1.2× 147 0.9× 12 0.2× 15 687
Julia K. Voice United States 13 576 2.1× 323 1.3× 233 1.3× 208 1.3× 51 0.9× 13 984
Silvia Naus United Kingdom 10 307 1.1× 55 0.2× 243 1.3× 244 1.5× 56 1.0× 11 757
Amir H. Salehi Canada 8 594 2.1× 273 1.1× 220 1.2× 82 0.5× 28 0.5× 13 873
Anikó Szabó United States 9 450 1.6× 114 0.5× 101 0.5× 69 0.4× 29 0.5× 17 757
Marianne Tuefferd Belgium 12 337 1.2× 109 0.4× 57 0.3× 171 1.1× 74 1.3× 24 703
Akiko Hamaguchi Japan 6 345 1.2× 157 0.6× 121 0.7× 79 0.5× 15 0.3× 6 518
Luke Oh United States 10 290 1.0× 120 0.5× 88 0.5× 87 0.5× 10 0.2× 11 655

Countries citing papers authored by Ernest Smith

Since Specialization
Citations

This map shows the geographic impact of Ernest Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Smith more than expected).

Fields of papers citing papers by Ernest Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Smith. The network helps show where Ernest Smith may publish in the future.

Co-authorship network of co-authors of Ernest Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Ernest Smith. A scholar is included among the top collaborators of Ernest Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernest Smith. Ernest Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Klenk, Christoph, Loretta Mueller, Elaine Gersz, et al.. (2023). A Vaccinia-based system for directed evolution of GPCRs in mammalian cells. Nature Communications. 14(1). 1770–1770. 5 indexed citations
3.
Evans, Elizabeth E., Vikas Mishra, Crystal Mallow, et al.. (2022). Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity. Journal of Neuroinflammation. 19(1). 200–200. 21 indexed citations
4.
5.
Lesinski, Gregory B., Terrence L. Fisher, Elizabeth E. Evans, et al.. (2019). Abstract CT016: Integrated biomarker trials of VX15/2503 (pepinemab) in combination with checkpoint inhibitors in window of opportunity studies in solid tumors. Cancer Research. 79(13_Supplement). CT016–CT016. 2 indexed citations
6.
Clavijo, Paúl E., Jay Friedman, Yvette Robbins, et al.. (2018). Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function. Cancer Immunology Research. 7(2). 282–291. 40 indexed citations
7.
Leonard, John E., Terrence L. Fisher, Laurie A. Winter, et al.. (2015). Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody. Molecular Cancer Therapeutics. 14(4). 964–972. 31 indexed citations
8.
Evans, Elizabeth E., Alan S. Jonason, Holm Bußler, et al.. (2015). Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunology Research. 3(6). 689–701. 88 indexed citations
9.
Southwell, Amber L., Sonia Franciosi, Erika B. Villanueva, et al.. (2015). Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease. Neurobiology of Disease. 76. 46–56. 87 indexed citations
10.
Fisher, Terrence L., Christine Reilly, Laurie A. Winter, et al.. (2015). Generation and preclinical characterization of an antibody specific for SEMA4D. mAbs. 8(1). 150–162. 36 indexed citations
11.
Klimatcheva, Ekaterina, Christine Reilly, Sebold Torno, et al.. (2015). CXCL13 antibody for the treatment of autoimmune disorders. BMC Immunology. 16(1). 6–6. 94 indexed citations
12.
Evans, Elizabeth E., Mark Paris, Ernest Smith, & Maurice Zauderer. (2015). Immunomodulation of the tumor microenvironment by neutralization of Semaphorin 4D. OncoImmunology. 4(12). e1054599–e1054599. 14 indexed citations
13.
Fisher, Terrence L., Christine Reilly, Virginia Litwin, et al.. (2015). Saturation monitoring of VX15/2503, a novel semaphorin 4D‐specific antibody, in clinical trials. Cytometry Part B Clinical Cytometry. 90(2). 199–208. 22 indexed citations
14.
Evans, Elizabeth E., Siwen Hu‐Lieskovan, Holm Bußler, et al.. (2015). Antibody blockade of semaphorin 4D breaks down barriers to enhance tumoricidal immune infiltration and supports rational immunotherapy combinations. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations
15.
Smith, Ernest & Maurice Zauderer. (2014). Antibody Library Display on a Mammalian Virus Vector: Combining the Advantages of Both Phage and Yeast Display into One Technology. Current Drug Discovery Technologies. 11(1). 48–55. 11 indexed citations
16.
Bauer, Stephen M., Marc A. Williams, Alan Howell, et al.. (2008). Maximizing Immune Responses: The Effects of Covalent Peptide Linkage to Beta-2-Microglobulin. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(5). 205–216. 2 indexed citations
17.
Evans, Elizabeth E., Alan S. Jonason, Mark Paris, et al.. (2006). C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Molecular Cancer Therapeutics. 5(11). 2919–2930. 43 indexed citations
18.
Smith, Ernest, et al.. (2004). Construction of cDNA Libraries in Vaccinia Virus. Humana Press eBooks. 65–75. 13 indexed citations
19.
Smith, Ernest, Elizabeth E. Evans, Loretta Mueller, et al.. (2001). Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens. Nature Medicine. 7(8). 967–972. 12 indexed citations
20.
Merchlinsky, Michael, et al.. (1997). Construction and Characterization of Vaccinia Direct Ligation Vectors. Virology. 238(2). 444–451. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley N. Davis Breakdown of academic impact, for papers by Sabrina A. Volpi Breakdown of academic impact, for papers by Cheryl D’Souza Breakdown of academic impact, for papers by Julia K. Voice Breakdown of academic impact, for papers by Silvia Naus Breakdown of academic impact, for papers by Amir H. Salehi Breakdown of academic impact, for papers by Anikó Szabó Breakdown of academic impact, for papers by Marianne Tuefferd Breakdown of academic impact, for papers by Akiko Hamaguchi Breakdown of academic impact, for papers by Luke Oh
Rankless by CCL
2026